Johnson & Johnson vs. XBiotech Inc
Johnson & Johnson (JNJ) comes out ahead, leading on 4 of 5 compared factors.
Size & Scale
| JNJ | XBIT | |
|---|---|---|
| Market Cap | $651.25 billion | $69.51 million |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | $-45,133,000 |
JNJ leads on 2 of 2 size & scale factors.
Valuation
| JNJ | XBIT | |
|---|---|---|
| P/E Ratio | 31.35 | — |
| Price / Book | 7.66 | 0.54 |
| Price / Sales | 6.65 | — |
XBIT leads on 1 of 1 valuation factors.
Profitability
| JNJ | XBIT | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | -35.13% |
JNJ leads on 1 of 1 profitability factors.
Dividend
| JNJ | XBIT | |
|---|---|---|
| Dividend Yield | 1.98% | — |
| Payout Ratio | 62.18 | — |
JNJ and XBIT split the dividend factors evenly.
Risk & Sentiment
| JNJ | XBIT | |
|---|---|---|
| Short Interest | 0.67% | 17.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, XBIT overview, XBIT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.